Clinical trial
Skin Sensitisation Test (Modified Draize-95) to Support a Low Dermatitis Potential Claim
NCT04402476 is registered in ClinicalTrials.gov with PT. Medisafe Technologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Skin Sensitisation Test (Modified Draize-95) to Support a Low Dermatitis Potential Claim
- Lead sponsor
- PT. Medisafe Technologies
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 23, 2019
- Completion date
- April 6, 2020
- Enrollment
- 208 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
skin sensitisation